Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 367

1.

Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD.

Scand J Gastroenterol. 2003 Jul;38(7):770-8.

PMID:
12889565
[PubMed - indexed for MEDLINE]
2.

Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.

Tsai WL, Cheng JS, Lai KH, Lin CP, Lo GH, Hsu PI, Yu HC, Lin CK, Chan HH, Chen WC, Chen TA, Li WL, Liang HL.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):304-11.

PMID:
19086330
[PubMed - indexed for MEDLINE]
3.
4.
5.

Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.

Huo T, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1301-8.

PMID:
15191512
[PubMed - indexed for MEDLINE]
Free Article
6.

Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.

Ohnishi K, Yoshioka H, Ito S, Fujiwara K.

Hepatology. 1998 Jan;27(1):67-72.

PMID:
9425919
[PubMed - indexed for MEDLINE]
7.

Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.

Ohnishi K.

Hepatogastroenterology. 1998 Aug;45 Suppl 3:1254-8.

PMID:
9730384
[PubMed - indexed for MEDLINE]
8.

Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.

Pompili M, Rapaccini GL, de Luca F, Caturelli E, Astone A, Siena DA, Villani MR, Grattagliano A, Cedrone A, Gasbarrini G.

Cancer. 1997 Apr 15;79(8):1501-8.

PMID:
9118030
[PubMed - indexed for MEDLINE]
9.

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.

Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, Villani MR, Cedrone A, Gasbarrini G.

Cancer. 2001 Jul 1;92(1):126-35.

PMID:
11443618
[PubMed - indexed for MEDLINE]
10.

Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.

Giorgio A, Tarantino L, de Stefano G, Perrotta A, Aloisio V, del Viscovo L, Alaia A, Lettieri G.

Eur J Ultrasound. 2000 Dec;12(2):145-54.

PMID:
11118922
[PubMed - indexed for MEDLINE]
11.

Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection.

Fartoux L, Arrive L, Andreani T, Serfaty L, Chazouillères O, Tubiana JM, Poupon R, Rosmorduc O.

Gastroenterol Clin Biol. 2005 Dec;29(12):1213-9.

PMID:
16518274
[PubMed - indexed for MEDLINE]
Free Article
12.

Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD.

Scand J Gastroenterol. 2004 Feb;39(2):168-73.

PMID:
15000280
[PubMed - indexed for MEDLINE]
13.

Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD.

Eur J Gastroenterol Hepatol. 2004 Mar;16(3):325-31.

PMID:
15195898
[PubMed - indexed for MEDLINE]
14.

Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.

Dettmer A, Kirchhoff TD, Gebel M, Zender L, Malek NP, Panning B, Chavan A, Rosenthal H, Kubicka S, Krusche S, Merkesdal S, Galanski M, Manns MP, Bleck JS.

World J Gastroenterol. 2006 Jun 21;12(23):3707-15.

PMID:
16773687
[PubMed - indexed for MEDLINE]
Free Article
15.

Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy.

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD.

Scand J Gastroenterol. 2002 Mar;37(3):350-5.

PMID:
11916199
[PubMed - indexed for MEDLINE]
16.

Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.

Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgrò G, Burroughs AK.

J Hepatol. 2010 Mar;52(3):380-8. doi: 10.1016/j.jhep.2009.12.004. Epub 2010 Jan 17.

PMID:
20149473
[PubMed - indexed for MEDLINE]
18.

Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.

Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V, Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A, Perri F.

Liver Transpl. 2004 Nov;10(11):1355-63.

PMID:
15497162
[PubMed - indexed for MEDLINE]
Free Article
19.

Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients.

Giorgio A, Tarantino L, Mariniello N, de Stefano G, Perrotta A, Aloisio V, Voza A, Finizia L, Alaia A, Del Viscovo L.

Eur J Ultrasound. 1998 Dec;8(3):201-6.

PMID:
9971904
[PubMed - indexed for MEDLINE]
20.

Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis.

Huo TI, Huang YH, Huang HC, Wu JC, Lee PC, Chang FY, Lee SD.

J Clin Gastroenterol. 2006 Aug;40(7):639-42.

PMID:
16917410
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk